US Broker Ratings

Maravai LifeSciences Holdings (MRVI): Analyst Consensus and Growth Potential Amid Challenging Metrics

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a prominent player in the biotechnology sector, has been a focal point for investors intrigued by its role in the life sciences industry. With..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Promising 62.78% Upside in Biotech Innovations

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a dynamic player in the biotechnology sector, is capturing investor attention with its promising pipeline in the treatment of inflammatory bowel disease (IBD). As a..

Savara, Inc. (SVRA) Stock Analysis: Exploring an 85% Potential Upside in the Biotech Sector

Savara, Inc. (NASDAQ: SVRA) is gaining attention in the biotechnology sector, thanks to its focus on addressing rare respiratory diseases. With a market capitalization of $1.19 billion, this clinical-stage biopharmaceutical..

SI-BONE, Inc. (SIBN) Stock Analysis: A 69.56% Potential Upside Amid Strong Buy Ratings

SI-BONE, Inc. (NASDAQ: SIBN), a healthcare industry contender specializing in medical devices, presents an intriguing opportunity for investors eyeing the growing field of musculoskeletal disorder treatments. The company, with a..

CeriBell, Inc. (CBLL) Stock Analysis: A 41% Upside Potential in Revolutionary Medical Devices

CeriBell, Inc. (CBLL) is a burgeoning name within the healthcare sector, specifically in the medical devices industry, and is making waves with its innovative approach to neurological diagnostics. Headquartered in..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 103% Potential Upside in Health Information Services

Simulations Plus, Inc. (SLP), a prominent player in the healthcare sector, has emerged as a compelling choice for investors seeking potential growth in the Health Information Services industry. Specializing in..

GH Research PLC (GHRS) Stock Analysis: Potential Upside of 124.74% and Strong Buy Ratings

Investors seeking opportunities in the healthcare sector should pay attention to GH Research PLC (NASDAQ: GHRS), a promising player in the biotechnology industry. Based in Dublin, Ireland, GH Research is..

uniQure N.V. (QURE) Stock Report: Exploring a 138% Potential Upside in the Biotech Arena

For investors with an eye on the biopharmaceutical sector, uniQure N.V. (NASDAQ: QURE) presents a compelling opportunity, marked by a significant potential upside of 138.58%. This Dutch-based biotechnology company, specializing..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Evaluating a 52.34% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Enliven Therapeutics, Inc. (NASDAQ: ELVN) a compelling opportunity, as the company is currently positioned with a significant potential upside of..

STAAR Surgical Company (STAA) Stock Analysis: Exploring a 37.81% Potential Upside for Investors

STAAR Surgical Company (NASDAQ: STAA), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing investment opportunity despite recent market fluctuations. Headquartered in Lake..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 20% Upside Potential in the Medical Devices Sector

iRadimed Corporation (NASDAQ: IRMD) has carved out a niche in the healthcare sector, specifically within the medical devices industry, by focusing on MRI-compatible equipment. Headquartered in Orlando, Florida, iRadimed is..

Immunome, Inc. (IMNM) Stock Analysis: A 56% Upside Potential in Biotechnology

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology company, is making waves in the healthcare sector with a focus on developing targeted cancer therapies. With a current market capitalization of $2.48..

Nutex Health Inc. (NUTX): Investor Outlook Highlights a Promising 138% Potential Upside

As healthcare remains a pivotal sector in the global economy, Nutex Health Inc. (NUTX) emerges as an intriguing player with a significant growth narrative. Operating within the United States, Nutex..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Emerging Potential with 90% Upside

For investors with a keen eye on the biotechnology sector, Nurix Therapeutics, Inc. (NASDAQ: NRIX) presents an intriguing opportunity. Headquartered in Brisbane, California, this clinical-stage biopharmaceutical company is making strides..

Geron Corporation (GERN) Stock Analysis: A Potential 108% Upside Opportunity in Biotechnology

For individual investors hunting for promising opportunities in the healthcare sector, Geron Corporation (NASDAQ: GERN) presents a compelling case with a potential upside of 108.59%. This biopharmaceutical company, headquartered in..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a Potential 18.52% Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a key player in the healthcare sector, has drawn considerable attention with its strategic focus on pain management medicines. As a specialty pharmaceutical company based..

Arcus Biosciences, Inc. (RCUS)

⚠️ No article content returned.

..

Intellia Therapeutics (NTLA) Investor Outlook: Exploring a 105% Potential Upside in Gene Editing Innovations

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneer in the burgeoning field of gene editing, is capturing investor attention with a staggering potential upside of 105.31%. The biotechnology company, headquartered in..

Salesforce, Inc. (CRM) Investor Outlook: Analyzing a 77% Potential Upside Amidst Market Volatility

Salesforce, Inc. (NYSE: CRM), a dominant player in the technology sector known for its comprehensive customer relationship management and innovative software solutions, is capturing investor attention with a significant potential..

PDF Solutions, Inc. (PDFS) Stock Analysis: Unveiling a 6.86% Potential Upside Amidst Robust Revenue Growth

PDF Solutions, Inc. (NASDAQ: PDFS), a player in the technology sector, particularly within the software application industry, is drawing attention with a market cap of $1.28 billion. With a current..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds